Generic Drug Product Development: International Regulatory Requirements for Bioequivalence (Drugs and the Pharmaceutical Sciences, 201) - Image 1

£62.59

CRC Press Generic Drug Product Development: International Regulatory Requirements for Bioequivalence (Drugs and the Pharmaceutical Sciences, 201)

Name: Generic Drug Product Development: International Regulatory Requirements for Bioequivalence (Drugs and the Pharmaceutical Sciences, 201)
Brand: CRC Press
Price: 59.51 GBP
Availability: InStock

Pharmacy - Dispensing

Price History & Forecast

Last 47 days • 47 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 47 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £62 (43 days, 91.5%)

Price range: £60 - £62

Price levels: 2 different prices over 47 days

Description

Due to a worldwide need for lower cost drug therapy, use of generic and multi-source drug products have been increasing. To meet international patent and trade agreements, the development and sale of these products must conform to national and international laws, and generic products must prove that they are of the same quality and are therapeutically equivalent to the brand name alternative. However, many countries have limited resources to inspect and verify the quality of all drug products for sale in their country. This title discusses the worldwide legislative and regulatory requirements for the registration of generic and multi-source drug products.

Product Specifications

Brand: CRC Press
Format: Paperback
ASIN: 036738437X
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Pharmacy - Dispensing
Domain: Amazon UK
Release Date: 27 September 2019
Listed Since: 25 June 2019

Barcode

No barcode data available

CRC Press Generic Drug Product Development: International Regulatory Requirements for Bioequivalence (Drugs and the Pharmaceutical Sciences, 201)

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Generic Drug Product Development: International Regulatory Requirements for Bioequivalence: 201 (Drugs and the Pharmaceutical Sciences)

CRC Press Generic Drug Product Development: Bioequivalence 180

Generic Drug Product Development: Solid Oral Dosage Forms, Second Edition: 129 (Drugs and the Pharmaceutical Sciences)

Handbook of Bioequivalence Testing (Drugs and the Pharmaceutical Sciences)

Pharmaceutical Product Development: Insights Into Pharmaceutical Processes, Management and Regulatory Affairs

Pharmaceutical Product Development: Insights Into Pharmaceutical Processes, Management and Regulatory Affairs

CRC Press - Biosimilar Drug Product Development Book

Biosimilar Drug Product Development (Drugs and the Pharmaceutical Sciences)

Biosimilars Development Strategies: Fast to Market Approaches

International Pharmaceutical Product Registration: 200 (Drugs and the Pharmaceutical Sciences)

Regulatory Affairs in the Pharmaceutical Industry

Analytical Aspects of Bioequivalence (Chromatographic Science Series)

Biologics and Biosimilars: Drug Discovery and Clinical Applications

Excipient Development for Pharmaceutical, Biotechnology, and Drug Delivery Systems

Good Pharmaceutical Manufacturing Practice: Rationale and Compliance

Good Pharmaceutical Manufacturing Practice: Rationale and Compliance

Poor Quality Pharmaceuticals in Global Public Health: 5 (Trust, 5)

FDA Regulatory Affairs: A Guide for Prescription Drugs, Medical Devices, and Biologics

Biosimilars and Interchangeable Biologics: Strategic Elements

Active Pharmaceutical Ingredients: Development, Manufacturing, and Regulation, Second Edition: 205 (Drugs and the Pharmaceutical Sciences)

Pharmaceutical Drug Product Development and Process Optimization: Effective Use of Quality by Design

Nonclinical Development of Novel Biologics, Biosimilars and Specialty Biologics

Biosimilars and Interchangeable Biologics: Tactical Elements

Biosimilars: A New Generation of Biologics